chr22-50721831-T-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001372044.2(SHANK3):āc.4184T>Gā(p.Val1395Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000782 in 1,558,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001372044.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHANK3 | NM_001372044.2 | c.4184T>G | p.Val1395Gly | missense_variant | 24/25 | ENST00000710353.1 | NP_001358973.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHANK3 | ENST00000262795.7 | c.3599T>G | p.Val1200Gly | missense_variant | 20/22 | 5 | ENSP00000489147 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000697 AC: 106AN: 152064Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000564 AC: 91AN: 161302Hom.: 0 AF XY: 0.000507 AC XY: 44AN XY: 86826
GnomAD4 exome AF: 0.000791 AC: 1113AN: 1406790Hom.: 0 Cov.: 34 AF XY: 0.000783 AC XY: 544AN XY: 694780
GnomAD4 genome AF: 0.000697 AC: 106AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.000538 AC XY: 40AN XY: 74408
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | SHANK3: BS1 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 06, 2020 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at